help button home button Am J Pathol JNCI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weller, P. F.
Right arrow Articles by Dvorak, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weller, P. F.
Right arrow Articles by Dvorak, A. M.

American Journal of Pathology, Vol 138, 141-148, Copyright © 1991 by American Society for Investigative Pathology


REGULAR ARTICLES

Cytoplasmic lipid bodies of human eosinophils. Subcellular isolation and analysis of arachidonate incorporation

PF Weller, RA Monahan-Earley, HF Dvorak and AM Dvorak
Department of Medicine, Harvard Medical School, Boston, Massachusetts.

Lipid bodies are non-membrane-bound cytoplasmic inclusions that are prominent in leukocytes engaged in inflammatory responses. As demonstrated by electron microscopic autoradiography, lipid bodies can serve as intracellular sites of 3H-arachidonic acid localization in eosinophils and other cells. To evaluate the role of lipid bodies as stores of esterified arachidonate, subcellular fractionation of lipid- body-rich human eosinophils was used to isolate lipid bodies free of other organelles. In lipid bodies isolated from 3H-arachidonate-labeled eosinophils, 3H-arachidonate was esterified almost totally in glycerolipids, predominantly in classes of phospholipids, including phosphatidyl-inositol and phosphatidylcholine. Lipid bodies, especially in leukocytes participating in inflammation, could represent intracellular sources of esterified arachidonate available for eicosanoid formation.


This article has been cited by other articles:


Home page
FASEB J.Home page
H.-C. Wan, R. C. N. Melo, Z. Jin, A. M. Dvorak, and P. F. Weller
Roles and origins of leukocyte lipid bodies: proteomic and ultrastructural studies
FASEB J, January 1, 2007; 21(1): 167 - 178.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Luo, S. M. Jones, M. Peters-Golden, and T. G. Brock
Nuclear localization of 5-lipoxygenase as a determinant of leukotriene B4 synthetic capacity
PNAS, October 14, 2003; 100(21): 12165 - 12170.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. F. de Assis, A. R. Silva, L. F. C. Caiado, G. K. Marathe, G. A. Zimmerman, S. M. Prescott, T. M. McIntyre, P. T. Bozza, and H. C. de Castro-Faria-Neto
Synergism Between Platelet-Activating Factor-Like Phospholipids and Peroxisome Proliferator-Activated Receptor {gamma} Agonists Generated During Low Density Lipoprotein Oxidation That Induces Lipid Body Formation in Leukocytes
J. Immunol., August 15, 2003; 171(4): 2090 - 2098.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Pacheco, F. A. Bozza, R. N. Gomes, M. Bozza, P. F. Weller, H. C. Castro-Faria-Neto, and P. T. Bozza
Lipopolysaccharide-Induced Leukocyte Lipid Body Formation In Vivo: Innate Immunity Elicited Intracellular Loci Involved in Eicosanoid Metabolism
J. Immunol., December 1, 2002; 169(11): 6498 - 6506.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. M. Scarfo, P. F. Weller, and H. W. Farber
Induction of endothelial cell cytoplasmic lipid bodies during hypoxia
Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H294 - H301.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
W. Yu, J. Cassara, and P. F. Weller
Phosphatidylinositide 3-kinase localizes to cytoplasmic lipid bodies in human polymorphonuclear leukocytes and other myeloid-derived cells
Blood, February 1, 2000; 95(3): 1078 - 1085.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
M. A. Giembycz and M. A. Lindsay
Pharmacology of the Eosinophil
Pharmacol. Rev., June 1, 1999; 51(2): 213 - 340.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. R. Bartemes, S. McKinney, G. J. Gleich, and H. Kita
Endogenous Platelet-Activating Factor Is Critically Involved in Effector Functions of Eosinophils Stimulated with IL-5 or IgG
J. Immunol., March 1, 1999; 162(5): 2982 - 2989.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
P. T. Bozza,  W. Yu, J. F. Penrose, E. S. Morgan, A. M. Dvorak, and P. F. Weller
Eosinophil Lipid Bodies: Specific, Inducible Intracellular Sites for Enhanced Eicosanoid Formation
J. Exp. Med., September 15, 1997; 186(6): 909 - 920.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Bandeira-Melo, M. Phoofolo, and P. F. Weller
Extranuclear Lipid Bodies, Elicited by CCR3-mediated Signaling Pathways, Are the Sites of Chemokine-enhanced Leukotriene C4 Production in Eosinophils and Basophils
J. Biol. Chem., June 15, 2001; 276(25): 22779 - 22787.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the American Society for Investigative Pathology.